VAERS reports by lot

GSK Varicella/Shingles lot 4LH35: VAERS reports

75 VAERS reports list lot 4LH35 as a GSK Varicella/Shingles vaccine, received between 2019-04-02 and 2020-09-15. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
75
Reports
3%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction7327%
General / Systemic (non-local)6826%
Neurological3212%
Musculoskeletal259%
Dermatological (non-injection-site)259%
Allergic / Anaphylactic135%
Gastrointestinal104%
Cardiac / Cardiovascular93%
Respiratory62%
Psychiatric / Neuropsychiatric31%
Autoimmune / Immune-mediated21%

Where reports came from

U.S. state of the reporter, where given (top 12).

Michigan8
Ohio6
Indiana5
Georgia4
Pennsylvania4
Alabama4
New York3
Nebraska3
New Jersey3
Missouri3
Tennessee3
West Virginia3

Reports by month received

2019-0431
2019-0513
2019-0614
2019-077
2019-083
2019-093
2019-103
2020-091

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.